Locations:

Tag: obstructive HCM

November 21, 2024/Heart, Vascular and Thoracic/Clinical Cardiology

REMS Update: Mavacamten Still Effective in Treating Real-World Patients With HCM

Few patients report left ventricular dysfunction or heart failure after one year

22-HVI-2769712_hyptertrophic-cardiomyopathy_650x450

April 5, 2022/Heart, Vascular and Thoracic/Clinical Cardiology

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

July 5, 2018/Heart, Vascular and Thoracic/Research

Sudden Death Risk in Obstructive HCM: Time to Refine the Criteria?

Large study suggests adding myectomy and afib to the equation

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy